Hologic Diagenode

What we do: Hologic Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. We specialize in epigenomics profiling services, sample preparation products for next-generation sequencing, proteomics, and epigenetics research. Our innovative portfolio includes Bioruptor® shearing and IP-Star® automation instruments, reagent kits, high-quality antibodies, and advanced epigenomics services. We serve researchers, diagnostic companies, and life sciences organizations worldwide, helping them accelerate biomarker discovery and validation through cutting-edge technologies and integrated bioinformatics.

Where we are located: Our headquarters are located at Liege Science Park, Rue Bois Saint Jean, 3, 4102 Liege (Seraing), Belgium. We also have a presence in New Jersey, USA, supporting our global operations and customer base.

Short history: Diagenode was founded in 2003 and has since become a recognized leader in epigenetics solutions. In March 2021, Diagenode was acquired by Hologic, Inc., a global innovator in medical technologies, further strengthening our capabilities and reach in the life sciences sector.

Organization & culture: With around 136 employees, Hologic Diagenode fosters a collaborative and innovative environment. Our team of epigenetics experts is committed to developing superior, easy-to-use products by actively engaging with customers and the scientific community. We value continuous improvement, scientific excellence, and teamwork to drive breakthroughs in epigenomics.

Recent developments: Diagenode has recently launched new innovations such as the Megaruptor shearing system for long fragment generation in sequencing and expanded its portfolio of fully automated systems and industry-validated antibodies. Our products are CE-marked and certified ISO 9001 and ISO 13485, reflecting our commitment to quality and regulatory standards.